Science News - January 14, 2026
New funding brings international top researchers to Finland
The Research Council of Finland (RCF) has allocated a total of 27.5 million euros for the recruitment of top-level researchers from outside Finland.
Funding - January 14, 2026
Up to USD 26.7 million for development of multivalent filovirus vaccines
The scientists will spearhead the development of new vaccines that aim to provide comprehensive protection against multiple lethal filoviruses, including Ebola virus, Sudan virus, Bundibugyo virus, and Marburg virus. Funding from CEPI and the European Union’s Horizon Europe programme Backed by up to USD 26.7 million in funding from CEPI and the European Union’s Horizon […]
Global report - January 14, 2026
AstraZeneca acquires Modella AI
AstraZeneca is acquiring its AI partner Modella AI to own and deploy multimodal AI foundation models in‑house across discovery and development.
Acquisition - January 13, 2026
Novartis buys radioligand peptide program from PepLib
Novartis agreed to pay USD 50 million in cash upfront (plus undisclosed milestones) for a peptide‑based radioligand oncology program from Zonsen PepLib Biotech.
Biotech Business - January 13, 2026
Evaxion expands AI-Immunology platform into autoimmune diseases
Thus, Evaxion will in the future work within cancers, infectious and autoimmune diseases as its core disease areas.
Global report - January 13, 2026
AbbVie and RemeGen in USD 5.6 billion oncology agreement
AbbVie and RemeGen have signed the first deal of the J.P Morgan Healthcare Conference 2026, with the companies agreeing to an exclusive oncology licensing agreement.
